The elderberry portfolio includes extracts standardized to 6% and 10% anthocyanins in both standard and organic grades.
PLT Health Solutions (Morristown, NJ) announced that it will be offering new elderberry extracts to the North American market. The elderberry portfolio includes extracts standardized to 6% and 10% anthocyanins in both standard and organic grades. Nektium Pharma (Las Palmas, Spain), PLT’s innovation partner, has secured long-term supply agreements with black elderberry growers in Central Europe, and will extract finished products at its facilities in the Canary Islands. The ingredients go through a per-batch testing program to ensure quality. These tests include fingerprint analysis for identification and quantification of anthocyanins, DNA sequential barcoding for authenticity, analysis for adulteration using the MALDI TOF technique, and standardization of biomarkers.
"As often happens with plant-based materials when demand spikes rapidly, there was a shortage of elderberry materials and a proliferation of sub-standard and adulterated products entering the market. All of us have read headlines of inferior elderberry offerings in the media," said Steve Fink, vice president of marketing for PLT Health Solutions, in a press release. "It has long been the mission of PLT Health Solutions to address industry pain points and to solve problems. With this line of traceable, standardized and lab-tested elderberry extracts, we believe PLT and Nektium have done that. Our organic offering adds additional value and can help our customers differentiate their products in the marketplace.”